Common variable immunodeficiency: A family study and therapeutic trial with cimetidine

Raphael Segal(Medical Council of Canada), E Zecler(Medical Council of Canada), Molly Dayan(Medical Council of Canada), Nava Epstein(University of Wisconsin–Madison), S Peller(Medical Council of Canada), Rita Michalevitch(Medical Council of Canada), Chaim Brautbar(Hadassah Academic College)

Journal of Allergy and Clinical Immunology

November 1, 1989

10.1016/0091-6749(89)90305-9

Cited by 17

Related Papers

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

|Blood|1998|1.9k

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

|Blood|1998|1.8k

Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.

|The EMBO Journal|1991|774

ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)

|The Lancet|1984|424

Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.

|Circulation|1994|383